Uniqure NV

Company Profile

Uniqure NV had its IPO on 2007-06-20 under the ticker symbol QURE.

The company operates in the Healthcare sector and Biotechnology industry. Uniqure NV has a staff strength of 501 employees.

Stock update

Shares of Uniqure NV opened at $7.88 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.53 - $7.9, and closed at $7.54.

This is a -4.31% slip from the previous day's closing price.

A total volume of 1,166,377 shares were traded at the close of the day’s session.

In the last one week, shares of Uniqure NV have slipped by -13.53%.

Uniqure NV's Key Ratios

Uniqure NV has a market cap of $375.91 million, indicating a price to book ratio of 2.6144 and a price to sales ratio of 17.5893.

In the last 12-months Uniqure NV’s revenue was $111.94 million with a gross profit of $-87370000 and an EBITDA of $-156528000. The EBITDA ratio measures Uniqure NV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Uniqure NV’s operating margin was -148.36% while its return on assets stood at -12.63% with a return of equity of -44.47%.

In Q2, Uniqure NV’s quarterly earnings growth was a negative -18.2% while revenue growth was a positive 387.3%.

Uniqure NV’s PE and PEG Ratio

Forward PE

27.933

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-3.96 per share while it has a forward price to earnings multiple of 27.933 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Uniqure NV’s profitability.

Uniqure NV stock is trading at a EV to sales ratio of 13.015 and a EV to EBITDA ratio of -7.3646. Its price to sales ratio in the trailing 12-months stood at 17.5893.

Uniqure NV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$942.77 million

Total Liabilities

$68.36 million

Operating Cash Flow

$45.83 million

Capital Expenditure

$1.07 million

Dividend Payout Ratio

0%

Uniqure NV ended 2024 with $942.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $942.77 million while shareholder equity stood at $353.32 million.

Uniqure NV ended 2024 with $0 in deferred long-term liabilities, $68.36 million in other current liabilities, 2877000.00 in common stock, $-727632000.00 in retained earnings and $26.02 million in goodwill. Its cash balance stood at $513.60 million and cash and short-term investments were $628.59 million. The company’s total short-term debt was $7,780,000 while long-term debt stood at $101.11 million.

Uniqure NV’s total current assets stands at $756.96 million while long-term investments were $0.00 and short-term investments were $114.99 million. Its net receivables were $102.56 million compared to accounts payable of $9.37 million and inventory worth $10.21 million.

In 2024, Uniqure NV's operating cash flow was $45.83 million while its capital expenditure stood at $1.07 million.

Comparatively, Uniqure NV paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$7.54

52-Week High

$28.255

52-Week Low

$7.4

Analyst Target Price

$36.71

Uniqure NV stock is currently trading at $7.54 per share. It touched a 52-week high of $28.255 and a 52-week low of $28.255. Analysts tracking the stock have a 12-month average target price of $36.71.

Its 50-day moving average was $9.46 and 200-day moving average was $17.87 The short ratio stood at 3 indicating a short percent outstanding of 0%.

Around 729.8% of the company’s stock are held by insiders while 9076% are held by institutions.